Newsletter April 2019
SHS is currently accepting investments in its fifth fund. The fund has already received capital commitments of over 100 million euros and is open to investors until 30 June 2019
SHS is currently accepting investments in its fifth fund. The fund has already received capital commitments of over 100 million euros and is open to investors until 30 June 2019. SHS has been investing in high-growth companies in the healthcare / medical technology sector in German-speaking countries as well as Scandinavia and the Benelux countries for almost 25 years now.
The fund’s targeted investments should have strong management teams as well as innovative products or business models. Their offer should cover yet unmet medical needs and thus have strong national and international growth potential. SHS invests in companies with marketable products that target growth or plan to permeate new markets. SHS supports its portfolio companies not only through its many years of experience and market knowledge, but also with its extensive network of contacts and partnerships.
An investment in the new SHS fund offers investors the opportunity to take advantage of opportunities in the world’s growing healthcare market and to benefit from the SHS team’s industry know-how. With its many years of experience in the healthcare sector, SHS has developed a proprietary deal flow and close relationships with medical technology companies, insurers and physicians.
If you are interested, we look forward to hearing from you by email to firstname.lastname@example.org or by phone at +49 7071 91690.